Valneva Gains 83% As Pfizer Invests $95M for Its Lyme Disease Program
(Valneva) Shares of Valneva SE jumped more than 83% on Tuesday following news Pfizer will invest €90.5 million or $95 million in the company. Valneva said that the deal involved…
Valneva’s Covid-19 Vaccine Candidate 87% Effective Against Omicron
(Valneva) Three doses of inactivated Covid-19 vaccine of biotech company Valneva have been found to have an 87% effectiveness against the Omicron variant. The vaccine candidate, VLA2001, which also carries…
UK Alleges Breach of Obligations in Terminating Vaccine Supply From Valneva SE
(Valneva) Specialty vaccine maker Valneva SE suffered a blow after the UK exercised a provision allowing it to terminate a supply deal for Covid-19 vaccines. The UK government cites a…
Valneva, the French Biotech that Could Save the World from Coronavirus Variants
Valneva SE, a small French biotech, is offering a vaccine that is more effective against variants of the coronavirus, according to Bloomberg. A participant from phase three trials could be…